Report from a National Cancer Institute (USA) workshop on quality of life assessment in cancer clinical trials

S. G. Nayfield*, P. A. Ganz, C. M. Moinpour, D. F. Cella, B. J. Hailey

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

113 Scopus citations

Abstract

To promote the inclusion of quality of life (QOL) end-points in clinical research on cancer, the National Cancer Institute (USA) sponsored a workshop on QOL assessment in cancer clinical trials in July, 1990. Experts in clinical trials and QOL research formed four working groups to identify current areas of cancer treatment in which QOL end-points are most important; to discuss methodologic problems in QOL assessment; to address common problems in implementing clinical studies with QOL end-points; and to consider statistical issues in design, implementation, and data analysis. Recommendations made by the working groups are summarized in this paper.

Original languageEnglish (US)
Pages (from-to)203-210
Number of pages8
JournalQuality of Life Research
Volume1
Issue number3
DOIs
StatePublished - Jun 1992

Keywords

  • Assessment methods
  • cancer
  • clinical trials
  • quality of life

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Fingerprint

Dive into the research topics of 'Report from a National Cancer Institute (USA) workshop on quality of life assessment in cancer clinical trials'. Together they form a unique fingerprint.

Cite this